Don't know about you, but the fundamental aim of this study seems grossly mis-placed.
The aim should be the best outcome for patients. That a best outcome might require changes to testing regimes is, in itself, fine. When the aim is "reduce", that will be the result.
We are living with the impact of reduced FT4 and minimal/rare FT3 testing in the UK. It is, in my book, impossible to assess the impact of reducing tests in the short term - such as in this paper. I mean, how many of us might have been diagnosed differently had we got FT4 and FT3 tests results from a long time ago? How much would full FT4 and FT3 testing contribute to the field of thyroidology?
Coming up with acronyms like PDSA doesn't hide the underlying fact that the aim is to save money.
Reducing free thyroid hormone testing through multiple Plan-Do-Study-Act cycles
JenniferTaher
Daniel R.Beriault
DrakeYip
ShafqatTahir
Lisa K.Hicks
Julie A.Gilmour
doi.org/10.1016/j.clinbioch...
Get Highlights
• Successfully decreased unnecessary fT4 and fT3 testing in a large tertiary hospital.
• Applying the Model for Improvement was pivotal in reducing fT4 and fT3 testing.
• Multiple plan-do-study-act (PDSA) cycles were required to achieve the project aim.
• Assessing balancing measures were important in refining change ideas.
• Post-implementation monitoring was vital in identifying implementation errors.
Abstract
Objectives
Free thyroid hormones (fT4 and fT3) are one of the most commonly ordered laboratory tests and often ordered when not clinically meaningful. Based on this, many studies have sought to identify strategies to reduce inappropriate fT4 and fT3 testing. The goal of the current study was to implement a quality improvement (QI) framework to identify an optimal approach to reducing inappropriate free thyroid hormone testing through multiple change ideas and Plan-Do-Study-Act (PDSA) cycles. The aim was to reduce fT4 and fT3 30% from baseline at a large tertiary hospital within 12 months.
Methods
The Model for Improvement Framework was used to implement a total of 3 change ideas in the first and second PDSA cycles. Change ideas included implementation and refinement of a free thyroid hormone forced function reflex system, modifications to test requisitions/order-entry interfaces, and a TSH-only option. Process and balancing measures were evaluated to fine-tune the change interventions. Data was continuously monitored pre and post interventions to assess progress, impact and potential errors.
Results
In the first PDSA cycle, laboratory testing of fT4 was decreased by 24% and fT3 by 18%. Soliciting physician feedback and assessing balancing measures was important in refining the approach. In the second PDSA cycle, fT4 was decreased by an additional 16% and fT3 by 29%. An audit of the process showed that phone calls to the laboratory to add-on free thyroid hormones did not increase after the second PDSA, averaging 2 calls per month.
Conclusions
To achieve optimal reductions in free thyroid hormone testing, multiple PDSA cycles were required alongside assessing process and balancing measures. Overall, fT4 and fT3 testing was decreased by 39% and 47%, respectively.
Keywords
free thyroid hormones
reflexive testing
laboratory utilization
quality improvement
balancing measures